Rheumatic Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria were the clinical diagnosis of tendinitis; bursitis or osteoarthritis and presence of pain resulting from rheumatic disease at the time of initial evaluation. Participants did not do any treatment for rheumatism two weeks before the start or during the clinical trial; or intra-articular corticosteroid injections in the previous three months.
Exclusion criteria
Exclusion criteria: We excluded patients with hypersensitivity to bee toxins, obesity, pregnancy and lactation, gastrointestinal bleeding history, gastric perforation; kidney disease, liver disease; current history of alcoholism, use of anticoagulants; implant prosthesis or pacemaker; severe chronic uncontrolled (hypertension, diabetes mellitus, heart disease and other diseases that by its nature or the proposed treatment could interfere with the assessment).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity decreased to articulate said recorded by visual numeric pain scale from obtaining reduction of 3 or more degrees of pain on said scale pre and post intervention.;Increased angulation range of motion (ROM) joint, checked with the goniometry technique, from the observation of an increase of over 30 degrees of ROM, pre and post intervention.;Improvement in muscle strength tested by manual muscle strength testing, with power increased in a statistically significant way, pre and post intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| No reported side effects, checked complaint from the researcher. It was reported no effect throughout the research. | — |
Countries
Brazil
Contacts
Pós Graduação em Ciências da Saúde